Dietrich Bruchmann
CEO
Dietrich joined in 2010 and built the company over the last 11 years. Prior to NUVISAN, he served in managerial positions at various companies—Hoechst, Celanese, Dupont, and PE—from 1984 until 2010. Dietrich has a PhD in chemistry.
Charles Bruchmann
Managing Director
Charles joined NUVISAN 2021 as after several years at the Porsche AG Group. In Summer 2023 he took over the responsibilities as Managing Director of the Nuvisan GmbH & Nuvisan ICB GmbH (Berlin).
Charles is an Engineer by training and currently enrolled in an MBA at the International University of Monaco.
Sylvie Villatte-Bruchmann
Chief Alliance Officer
Sylvie joined NUVISAN in early 2011 having worked predominantly in business development. Sylvie has been working in CRO for 20 years, and before that, she worked in hospitals.
Achim Freisleben
Managing Director | Site Neu-Ulm
& Chief Operating Officer
Achim joined NUVISAN in 2016 with the acquisition of the Grafing site from Merck KGaA. He has headed up the global bioanalytical service area ever since, and as of January 1, 2021, he is responsible for the overall operations in the development area.
He has almost 20 years of experience in CRO, biotech, and medium pharma R&D, with a focus on analytical, GxP, and DMPK. He holds a PhD in food chemistry from the Technical University of Munich.
Pierre Diebolt
Managing Director France
Pierre joined in 2018 as Managing Director of NUVISAN France, after 25 years of experience in the health care industry (Galderma, Nestlé Skin Health, Laboratoires Fournier, Pierre Fabre).
Pierre is a biochemist by training and a qualified European Patent Attorney. He also holds an MBA from the International University of Monaco.
Joerg Fanghaenel
Chief Operating Officer | Site Berlin
Joerg joined NUVISAN as EVP of Head Lead Discovery in July 2020.
He has 15 years of pharma experience at Bayer in different R&D positions and roles in the exciting field of drug discovery, including protein technologies, structural biology, and high-throughput screening.
Piet Swart
Chief Scientific Officer
Piet joined NUVISAN as site head of the DMPK expert center in Grafing. As a successful turnaround, Piet is now a board member and Chief Scientific Officer of the company.
Piet has over 30 years of experience in non-clinical and early clinical development in large pharma. He holds a degree in pharmaceutical medicine and is a registered pharmacologist.